These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6205402)

  • 1. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.
    Kokubun S; Reuter H
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4824-7. PubMed ID: 6205402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.
    Affolter H; Coronado R
    Biophys J; 1985 Aug; 48(2):341-7. PubMed ID: 2413915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyridine Ca2+ agonists and channel blockers interact in the opposite manner with photogenerated unpaired electrons.
    Marinov BS; Saxon ME
    FEBS Lett; 1985 Jul; 186(2):251-4. PubMed ID: 2408923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent.
    Thomas G; Chung M; Cohen CJ
    Circ Res; 1985 Jan; 56(1):87-96. PubMed ID: 2578336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.
    Hess P; Lansman JB; Tsien RW
    Nature; 1984 Oct 11-17; 311(5986):538-44. PubMed ID: 6207437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644.
    Nowycky MC; Fox AP; Tsien RW
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2178-82. PubMed ID: 2580308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow channel calcium activators, a new group of pharmacological agents.
    Preuss KC; Gross GJ; Brooks HL; Warltier DC
    Life Sci; 1985 Oct; 37(14):1271-8. PubMed ID: 2413326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The agonist effect of dihydropyridines on Ca channels.
    Brown AM; Kunze DL; Yatani A
    Nature; 1984 Oct 11-17; 311(5986):570-2. PubMed ID: 6207438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage-dependence of Ca2+ agonist effect of YC-170 on cardiac L-type Ca2+ channels.
    Takeda Y; Tohse N; Nakaya H; Kanno M
    Br J Pharmacol; 1995 Oct; 116(3):2134-40. PubMed ID: 8640356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists.
    Tsien RW; Bean BP; Hess P; Lansman JB; Nilius B; Nowycky MC
    J Mol Cell Cardiol; 1986 Jul; 18(7):691-710. PubMed ID: 2427730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
    Takeda Y
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):557-69. PubMed ID: 7687975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Ca2+ and K+ currents in bag cell neurons of Aplysia californica by dihydropyridine Ca2+ antagonists.
    Nerbonne JM; Gurney AM
    J Neurosci; 1987 Mar; 7(3):882-93. PubMed ID: 2435867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Ca channels in heart muscle by a new dihydropyridine derivative.
    Nilius B
    Gen Physiol Biophys; 1984 Oct; 3(5):437-40. PubMed ID: 6210228
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives.
    Renaud JF; Méaux JP; Romey G; Schmid A; Lazdunski M
    Biochem Biophys Res Commun; 1984 Nov; 125(1):405-12. PubMed ID: 6210086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium entry activators: distinct sites of dihydropyridine and aminopyridine action.
    Greenberg DA; Cooper EC; Carpenter CL
    Neurosci Lett; 1984 Sep; 50(1-3):279-82. PubMed ID: 6208517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.
    Schramm M; Thomas G; Towart R; Franckowiak G
    Nature; 1983 Jun 9-15; 303(5917):535-7. PubMed ID: 6190088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
    Young W; Chen J; Jung F; Gardner P
    Mol Pharmacol; 1988 Sep; 34(3):239-44. PubMed ID: 2458520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels.
    Franckowiak G; Bechem M; Schramm M; Thomas G
    Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blocking drugs. Part I: The calcium channel.
    Brill DM; Fozzard HA
    Compr Ther; 1985 Oct; 11(10):60-6. PubMed ID: 2414053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.